Please note: The information displayed on this page might be outdated.
PAION AG: Remimazolam: short-acting anesthetic. Ph 3 study in procedural sedation in US. Safety data in ASA III/IV patients in Ph 3 colonoscopy study and Ph 3 bronchoscopy study. US approval filed by partner Cosmo Pharmaceuticals in June 2019. Initiated Ph 3 in general anesthesia in EU in July 2018, exp completion 2020.
Based in...
Clinical Stage
Phase III
Disease Space
Central Nervous System, Pain
Biotechnology, Specialty Pharmaceutical
Public, USA
Market Cap
100MM - 500MM
Martin Strasse 10
Aachen, Nordrhein-Westfalen 52062

Company Participants at Solebury Trout Virtual Global Healthcare Conference Series

  • James Phillips, CEO

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Top 10 Holders of PAION AG

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
TIAA-CREF Investment Management LLC 3.97 2,536,453 8.37 Funds 2020-04-30
Baring Asset Management Ltd. 0.86 548,024 1.81 Funds 2020-02-29
Mandarine Gestion SA 0.52 330,000 1.09 Funds 2020-02-28
FPS Vermögensverwaltung GmbH 0.39 246,573 0.81 Funds 2019-12-31
Lampe Asset Management GmbH 0.05 34,400 0.11 Funds 2020-04-30
Baader Bank AG (Investment Management) 0.05 30,000 0.10 Funds 2020-05-29
Gutmann Finanz Strategien AG 0.03 22,292 0.07 Funds 2020-03-31
Wallberg Invest SA 0.02 11,000 0.04 Funds 2019-12-31
Messieurs Hottinguer & Cie Gestion Privée SA 0.02 10,435 0.03 Funds 2019-10-31
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.